nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Mycophenolic acid—systemic scleroderma	0.445	0.642	CbGbCtD
Raltegravir—UGT1A1—Mycophenolate mofetil—systemic scleroderma	0.249	0.358	CbGbCtD
Raltegravir—CCR1—connective tissue—systemic scleroderma	0.00506	0.302	CbGeAlD
Raltegravir—CCR1—digestive system—systemic scleroderma	0.00366	0.218	CbGeAlD
Raltegravir—CCR1—tendon—systemic scleroderma	0.00348	0.208	CbGeAlD
Raltegravir—CCR1—lung—systemic scleroderma	0.00305	0.182	CbGeAlD
Raltegravir—UGT1A1—digestive system—systemic scleroderma	0.0015	0.0897	CbGeAlD
Raltegravir—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000171	0.000591	CcSEcCtD
Raltegravir—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000171	0.00059	CcSEcCtD
Raltegravir—Neutropenia—Prednisone—systemic scleroderma	0.000171	0.000589	CcSEcCtD
Raltegravir—Abdominal pain—Azathioprine—systemic scleroderma	0.00017	0.000588	CcSEcCtD
Raltegravir—Body temperature increased—Azathioprine—systemic scleroderma	0.00017	0.000588	CcSEcCtD
Raltegravir—Skin disorder—Lisinopril—systemic scleroderma	0.00017	0.000586	CcSEcCtD
Raltegravir—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000584	CcSEcCtD
Raltegravir—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000169	0.000583	CcSEcCtD
Raltegravir—Diarrhoea—Captopril—systemic scleroderma	0.000169	0.000583	CcSEcCtD
Raltegravir—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000169	0.000582	CcSEcCtD
Raltegravir—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000582	CcSEcCtD
Raltegravir—Erectile dysfunction—Prednisone—systemic scleroderma	0.000168	0.00058	CcSEcCtD
Raltegravir—Feeling abnormal—Leflunomide—systemic scleroderma	0.000168	0.000579	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000168	0.000578	CcSEcCtD
Raltegravir—Fatigue—Mycophenolic acid—systemic scleroderma	0.000167	0.000578	CcSEcCtD
Raltegravir—Mood swings—Methotrexate—systemic scleroderma	0.000167	0.000577	CcSEcCtD
Raltegravir—Nausea—Mometasone—systemic scleroderma	0.000167	0.000576	CcSEcCtD
Raltegravir—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000166	0.000574	CcSEcCtD
Raltegravir—Weight increased—Prednisone—systemic scleroderma	0.000166	0.000574	CcSEcCtD
Raltegravir—Pain—Mycophenolic acid—systemic scleroderma	0.000166	0.000573	CcSEcCtD
Raltegravir—Constipation—Mycophenolic acid—systemic scleroderma	0.000166	0.000573	CcSEcCtD
Raltegravir—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000573	CcSEcCtD
Raltegravir—Weight decreased—Prednisone—systemic scleroderma	0.000165	0.00057	CcSEcCtD
Raltegravir—Hyperglycaemia—Prednisone—systemic scleroderma	0.000165	0.000569	CcSEcCtD
Raltegravir—Cough—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000565	CcSEcCtD
Raltegravir—Dizziness—Captopril—systemic scleroderma	0.000163	0.000563	CcSEcCtD
Raltegravir—Depression—Prednisone—systemic scleroderma	0.000162	0.00056	CcSEcCtD
Raltegravir—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000559	CcSEcCtD
Raltegravir—Urticaria—Leflunomide—systemic scleroderma	0.000162	0.000558	CcSEcCtD
Raltegravir—Abdominal pain—Leflunomide—systemic scleroderma	0.000161	0.000555	CcSEcCtD
Raltegravir—Body temperature increased—Leflunomide—systemic scleroderma	0.000161	0.000555	CcSEcCtD
Raltegravir—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00016	0.000554	CcSEcCtD
Raltegravir—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00016	0.000552	CcSEcCtD
Raltegravir—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000552	CcSEcCtD
Raltegravir—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000552	CcSEcCtD
Raltegravir—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000552	CcSEcCtD
Raltegravir—Myocardial infarction—Prednisone—systemic scleroderma	0.00016	0.000551	CcSEcCtD
Raltegravir—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00016	0.000551	CcSEcCtD
Raltegravir—Breast disorder—Methotrexate—systemic scleroderma	0.00016	0.000551	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000159	0.00055	CcSEcCtD
Raltegravir—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000159	0.00055	CcSEcCtD
Raltegravir—Hypersensitivity—Azathioprine—systemic scleroderma	0.000159	0.000548	CcSEcCtD
Raltegravir—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000159	0.000548	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000548	CcSEcCtD
Raltegravir—Insomnia—Lisinopril—systemic scleroderma	0.000158	0.000546	CcSEcCtD
Raltegravir—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000545	CcSEcCtD
Raltegravir—Paraesthesia—Lisinopril—systemic scleroderma	0.000157	0.000542	CcSEcCtD
Raltegravir—Vomiting—Captopril—systemic scleroderma	0.000157	0.000542	CcSEcCtD
Raltegravir—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000539	CcSEcCtD
Raltegravir—Rash—Captopril—systemic scleroderma	0.000156	0.000537	CcSEcCtD
Raltegravir—Dermatitis—Captopril—systemic scleroderma	0.000156	0.000537	CcSEcCtD
Raltegravir—Somnolence—Lisinopril—systemic scleroderma	0.000155	0.000536	CcSEcCtD
Raltegravir—Headache—Captopril—systemic scleroderma	0.000155	0.000534	CcSEcCtD
Raltegravir—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000533	CcSEcCtD
Raltegravir—Dyspepsia—Lisinopril—systemic scleroderma	0.000154	0.000531	CcSEcCtD
Raltegravir—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000153	0.00053	CcSEcCtD
Raltegravir—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000153	0.00053	CcSEcCtD
Raltegravir—Infection—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000525	CcSEcCtD
Raltegravir—Decreased appetite—Lisinopril—systemic scleroderma	0.000152	0.000525	CcSEcCtD
Raltegravir—Eosinophilia—Methotrexate—systemic scleroderma	0.000151	0.000522	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000151	0.000521	CcSEcCtD
Raltegravir—Fatigue—Lisinopril—systemic scleroderma	0.000151	0.00052	CcSEcCtD
Raltegravir—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000519	CcSEcCtD
Raltegravir—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000518	CcSEcCtD
Raltegravir—Hypersensitivity—Leflunomide—systemic scleroderma	0.00015	0.000517	CcSEcCtD
Raltegravir—Pain—Lisinopril—systemic scleroderma	0.00015	0.000516	CcSEcCtD
Raltegravir—Constipation—Lisinopril—systemic scleroderma	0.00015	0.000516	CcSEcCtD
Raltegravir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000514	CcSEcCtD
Raltegravir—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000511	CcSEcCtD
Raltegravir—Diarrhoea—Azathioprine—systemic scleroderma	0.000147	0.000509	CcSEcCtD
Raltegravir—Nausea—Captopril—systemic scleroderma	0.000147	0.000506	CcSEcCtD
Raltegravir—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000146	0.000505	CcSEcCtD
Raltegravir—Asthenia—Leflunomide—systemic scleroderma	0.000146	0.000504	CcSEcCtD
Raltegravir—Hallucination—Prednisone—systemic scleroderma	0.000145	0.000502	CcSEcCtD
Raltegravir—Feeling abnormal—Lisinopril—systemic scleroderma	0.000144	0.000497	CcSEcCtD
Raltegravir—Pruritus—Leflunomide—systemic scleroderma	0.000144	0.000497	CcSEcCtD
Raltegravir—Connective tissue disorder—Prednisone—systemic scleroderma	0.000144	0.000496	CcSEcCtD
Raltegravir—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000143	0.000493	CcSEcCtD
Raltegravir—Neutropenia—Methotrexate—systemic scleroderma	0.000143	0.000493	CcSEcCtD
Raltegravir—Dizziness—Azathioprine—systemic scleroderma	0.000142	0.000492	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000142	0.00049	CcSEcCtD
Raltegravir—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000141	0.000485	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00014	0.000482	CcSEcCtD
Raltegravir—Asthenia—Mycophenolic acid—systemic scleroderma	0.000139	0.000481	CcSEcCtD
Raltegravir—Diarrhoea—Leflunomide—systemic scleroderma	0.000139	0.000481	CcSEcCtD
Raltegravir—Urticaria—Lisinopril—systemic scleroderma	0.000139	0.000479	CcSEcCtD
Raltegravir—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000478	CcSEcCtD
Raltegravir—Body temperature increased—Lisinopril—systemic scleroderma	0.000138	0.000477	CcSEcCtD
Raltegravir—Abdominal pain—Lisinopril—systemic scleroderma	0.000138	0.000477	CcSEcCtD
Raltegravir—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000475	CcSEcCtD
Raltegravir—Pruritus—Mycophenolic acid—systemic scleroderma	0.000137	0.000474	CcSEcCtD
Raltegravir—Vomiting—Azathioprine—systemic scleroderma	0.000137	0.000473	CcSEcCtD
Raltegravir—Eye disorder—Prednisone—systemic scleroderma	0.000137	0.000471	CcSEcCtD
Raltegravir—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000136	0.00047	CcSEcCtD
Raltegravir—Infestation—Methotrexate—systemic scleroderma	0.000136	0.00047	CcSEcCtD
Raltegravir—Infestation NOS—Methotrexate—systemic scleroderma	0.000136	0.00047	CcSEcCtD
Raltegravir—Rash—Azathioprine—systemic scleroderma	0.000136	0.000469	CcSEcCtD
Raltegravir—Dermatitis—Azathioprine—systemic scleroderma	0.000136	0.000468	CcSEcCtD
Raltegravir—Depression—Methotrexate—systemic scleroderma	0.000136	0.000468	CcSEcCtD
Raltegravir—Headache—Azathioprine—systemic scleroderma	0.000135	0.000466	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000135	0.000466	CcSEcCtD
Raltegravir—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000465	CcSEcCtD
Raltegravir—Dizziness—Leflunomide—systemic scleroderma	0.000135	0.000464	CcSEcCtD
Raltegravir—Renal failure—Methotrexate—systemic scleroderma	0.000134	0.000462	CcSEcCtD
Raltegravir—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000133	0.00046	CcSEcCtD
Raltegravir—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000133	0.000458	CcSEcCtD
Raltegravir—Angiopathy—Prednisone—systemic scleroderma	0.000133	0.000458	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000456	CcSEcCtD
Raltegravir—Immune system disorder—Prednisone—systemic scleroderma	0.000132	0.000456	CcSEcCtD
Raltegravir—Pain—Mycophenolate mofetil—systemic scleroderma	0.000131	0.000452	CcSEcCtD
Raltegravir—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000131	0.000452	CcSEcCtD
Raltegravir—Haematuria—Methotrexate—systemic scleroderma	0.00013	0.000448	CcSEcCtD
Raltegravir—Vomiting—Leflunomide—systemic scleroderma	0.000129	0.000447	CcSEcCtD
Raltegravir—Alopecia—Prednisone—systemic scleroderma	0.000129	0.000446	CcSEcCtD
Raltegravir—Hypersensitivity—Lisinopril—systemic scleroderma	0.000129	0.000445	CcSEcCtD
Raltegravir—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000129	0.000444	CcSEcCtD
Raltegravir—Dizziness—Mycophenolic acid—systemic scleroderma	0.000128	0.000443	CcSEcCtD
Raltegravir—Epistaxis—Methotrexate—systemic scleroderma	0.000128	0.000443	CcSEcCtD
Raltegravir—Rash—Leflunomide—systemic scleroderma	0.000128	0.000443	CcSEcCtD
Raltegravir—Dermatitis—Leflunomide—systemic scleroderma	0.000128	0.000442	CcSEcCtD
Raltegravir—Mental disorder—Prednisone—systemic scleroderma	0.000128	0.000442	CcSEcCtD
Raltegravir—Nausea—Azathioprine—systemic scleroderma	0.000128	0.000442	CcSEcCtD
Raltegravir—Headache—Leflunomide—systemic scleroderma	0.000127	0.00044	CcSEcCtD
Raltegravir—Erythema—Prednisone—systemic scleroderma	0.000127	0.000439	CcSEcCtD
Raltegravir—Malnutrition—Prednisone—systemic scleroderma	0.000127	0.000439	CcSEcCtD
Raltegravir—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000126	0.000436	CcSEcCtD
Raltegravir—Asthenia—Lisinopril—systemic scleroderma	0.000125	0.000433	CcSEcCtD
Raltegravir—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000432	CcSEcCtD
Raltegravir—Pruritus—Lisinopril—systemic scleroderma	0.000124	0.000427	CcSEcCtD
Raltegravir—Vomiting—Mycophenolic acid—systemic scleroderma	0.000123	0.000426	CcSEcCtD
Raltegravir—Rash—Mycophenolic acid—systemic scleroderma	0.000122	0.000422	CcSEcCtD
Raltegravir—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000122	0.000422	CcSEcCtD
Raltegravir—Hepatitis—Methotrexate—systemic scleroderma	0.000122	0.000422	CcSEcCtD
Raltegravir—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000122	0.00042	CcSEcCtD
Raltegravir—Headache—Mycophenolic acid—systemic scleroderma	0.000122	0.00042	CcSEcCtD
Raltegravir—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000418	CcSEcCtD
Raltegravir—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000418	CcSEcCtD
Raltegravir—Nausea—Leflunomide—systemic scleroderma	0.000121	0.000417	CcSEcCtD
Raltegravir—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000121	0.000416	CcSEcCtD
Raltegravir—Urethral disorder—Methotrexate—systemic scleroderma	0.00012	0.000413	CcSEcCtD
Raltegravir—Diarrhoea—Lisinopril—systemic scleroderma	0.00012	0.000413	CcSEcCtD
Raltegravir—Ill-defined disorder—Prednisone—systemic scleroderma	0.000118	0.000407	CcSEcCtD
Raltegravir—Visual impairment—Methotrexate—systemic scleroderma	0.000118	0.000406	CcSEcCtD
Raltegravir—Anaemia—Prednisone—systemic scleroderma	0.000118	0.000406	CcSEcCtD
Raltegravir—Agitation—Prednisone—systemic scleroderma	0.000117	0.000404	CcSEcCtD
Raltegravir—Dizziness—Lisinopril—systemic scleroderma	0.000116	0.000399	CcSEcCtD
Raltegravir—Erythema multiforme—Methotrexate—systemic scleroderma	0.000115	0.000399	CcSEcCtD
Raltegravir—Nausea—Mycophenolic acid—systemic scleroderma	0.000115	0.000398	CcSEcCtD
Raltegravir—Malaise—Prednisone—systemic scleroderma	0.000115	0.000396	CcSEcCtD
Raltegravir—Vertigo—Prednisone—systemic scleroderma	0.000114	0.000395	CcSEcCtD
Raltegravir—Eye disorder—Methotrexate—systemic scleroderma	0.000114	0.000394	CcSEcCtD
Raltegravir—Tinnitus—Methotrexate—systemic scleroderma	0.000114	0.000393	CcSEcCtD
Raltegravir—Cardiac disorder—Methotrexate—systemic scleroderma	0.000113	0.000391	CcSEcCtD
Raltegravir—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000113	0.00039	CcSEcCtD
Raltegravir—Vomiting—Lisinopril—systemic scleroderma	0.000111	0.000384	CcSEcCtD
Raltegravir—Angiopathy—Methotrexate—systemic scleroderma	0.000111	0.000383	CcSEcCtD
Raltegravir—Immune system disorder—Methotrexate—systemic scleroderma	0.00011	0.000381	CcSEcCtD
Raltegravir—Rash—Lisinopril—systemic scleroderma	0.00011	0.00038	CcSEcCtD
Raltegravir—Dermatitis—Lisinopril—systemic scleroderma	0.00011	0.00038	CcSEcCtD
Raltegravir—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00011	0.00038	CcSEcCtD
Raltegravir—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000379	CcSEcCtD
Raltegravir—Hypertension—Prednisone—systemic scleroderma	0.00011	0.000379	CcSEcCtD
Raltegravir—Chills—Methotrexate—systemic scleroderma	0.00011	0.000378	CcSEcCtD
Raltegravir—Headache—Lisinopril—systemic scleroderma	0.00011	0.000378	CcSEcCtD
Raltegravir—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000374	CcSEcCtD
Raltegravir—Arthralgia—Prednisone—systemic scleroderma	0.000108	0.000374	CcSEcCtD
Raltegravir—Myalgia—Prednisone—systemic scleroderma	0.000108	0.000374	CcSEcCtD
Raltegravir—Anxiety—Prednisone—systemic scleroderma	0.000108	0.000373	CcSEcCtD
Raltegravir—Alopecia—Methotrexate—systemic scleroderma	0.000108	0.000373	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000108	0.000371	CcSEcCtD
Raltegravir—Discomfort—Prednisone—systemic scleroderma	0.000107	0.000369	CcSEcCtD
Raltegravir—Mental disorder—Methotrexate—systemic scleroderma	0.000107	0.000369	CcSEcCtD
Raltegravir—Malnutrition—Methotrexate—systemic scleroderma	0.000106	0.000367	CcSEcCtD
Raltegravir—Erythema—Methotrexate—systemic scleroderma	0.000106	0.000367	CcSEcCtD
Raltegravir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000362	CcSEcCtD
Raltegravir—Dysgeusia—Methotrexate—systemic scleroderma	0.000104	0.000359	CcSEcCtD
Raltegravir—Nausea—Lisinopril—systemic scleroderma	0.000104	0.000358	CcSEcCtD
Raltegravir—Infection—Prednisone—systemic scleroderma	0.000103	0.000356	CcSEcCtD
Raltegravir—Back pain—Methotrexate—systemic scleroderma	0.000103	0.000355	CcSEcCtD
Raltegravir—Nervous system disorder—Prednisone—systemic scleroderma	0.000102	0.000351	CcSEcCtD
Raltegravir—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000101	0.00035	CcSEcCtD
Raltegravir—Skin disorder—Prednisone—systemic scleroderma	0.000101	0.000348	CcSEcCtD
Raltegravir—Hyperhidrosis—Prednisone—systemic scleroderma	0.0001	0.000346	CcSEcCtD
Raltegravir—Ill-defined disorder—Methotrexate—systemic scleroderma	9.87e-05	0.000341	CcSEcCtD
Raltegravir—Anaemia—Methotrexate—systemic scleroderma	9.83e-05	0.000339	CcSEcCtD
Raltegravir—Vomiting—Mycophenolate mofetil—systemic scleroderma	9.74e-05	0.000336	CcSEcCtD
Raltegravir—Rash—Mycophenolate mofetil—systemic scleroderma	9.66e-05	0.000333	CcSEcCtD
Raltegravir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.65e-05	0.000333	CcSEcCtD
Raltegravir—Headache—Mycophenolate mofetil—systemic scleroderma	9.6e-05	0.000331	CcSEcCtD
Raltegravir—Malaise—Methotrexate—systemic scleroderma	9.59e-05	0.000331	CcSEcCtD
Raltegravir—Vertigo—Methotrexate—systemic scleroderma	9.55e-05	0.00033	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.46e-05	0.000327	CcSEcCtD
Raltegravir—Insomnia—Prednisone—systemic scleroderma	9.39e-05	0.000324	CcSEcCtD
Raltegravir—Paraesthesia—Prednisone—systemic scleroderma	9.32e-05	0.000322	CcSEcCtD
Raltegravir—Cough—Methotrexate—systemic scleroderma	9.28e-05	0.00032	CcSEcCtD
Raltegravir—Dyspepsia—Prednisone—systemic scleroderma	9.14e-05	0.000315	CcSEcCtD
Raltegravir—Nausea—Mycophenolate mofetil—systemic scleroderma	9.1e-05	0.000314	CcSEcCtD
Raltegravir—Myalgia—Methotrexate—systemic scleroderma	9.05e-05	0.000312	CcSEcCtD
Raltegravir—Chest pain—Methotrexate—systemic scleroderma	9.05e-05	0.000312	CcSEcCtD
Raltegravir—Arthralgia—Methotrexate—systemic scleroderma	9.05e-05	0.000312	CcSEcCtD
Raltegravir—Decreased appetite—Prednisone—systemic scleroderma	9.03e-05	0.000312	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	8.99e-05	0.00031	CcSEcCtD
Raltegravir—Fatigue—Prednisone—systemic scleroderma	8.95e-05	0.000309	CcSEcCtD
Raltegravir—Discomfort—Methotrexate—systemic scleroderma	8.94e-05	0.000309	CcSEcCtD
Raltegravir—Constipation—Prednisone—systemic scleroderma	8.88e-05	0.000306	CcSEcCtD
Raltegravir—Confusional state—Methotrexate—systemic scleroderma	8.75e-05	0.000302	CcSEcCtD
Raltegravir—Infection—Methotrexate—systemic scleroderma	8.62e-05	0.000298	CcSEcCtD
Raltegravir—Feeling abnormal—Prednisone—systemic scleroderma	8.56e-05	0.000295	CcSEcCtD
Raltegravir—Nervous system disorder—Methotrexate—systemic scleroderma	8.51e-05	0.000294	CcSEcCtD
Raltegravir—Thrombocytopenia—Methotrexate—systemic scleroderma	8.5e-05	0.000293	CcSEcCtD
Raltegravir—Gastrointestinal pain—Prednisone—systemic scleroderma	8.49e-05	0.000293	CcSEcCtD
Raltegravir—Skin disorder—Methotrexate—systemic scleroderma	8.43e-05	0.000291	CcSEcCtD
Raltegravir—Hyperhidrosis—Methotrexate—systemic scleroderma	8.39e-05	0.00029	CcSEcCtD
Raltegravir—Urticaria—Prednisone—systemic scleroderma	8.25e-05	0.000285	CcSEcCtD
Raltegravir—Body temperature increased—Prednisone—systemic scleroderma	8.21e-05	0.000283	CcSEcCtD
Raltegravir—Abdominal pain—Prednisone—systemic scleroderma	8.21e-05	0.000283	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	7.91e-05	0.000273	CcSEcCtD
Raltegravir—Insomnia—Methotrexate—systemic scleroderma	7.85e-05	0.000271	CcSEcCtD
Raltegravir—Paraesthesia—Methotrexate—systemic scleroderma	7.79e-05	0.000269	CcSEcCtD
Raltegravir—Somnolence—Methotrexate—systemic scleroderma	7.71e-05	0.000266	CcSEcCtD
Raltegravir—Hypersensitivity—Prednisone—systemic scleroderma	7.65e-05	0.000264	CcSEcCtD
Raltegravir—Dyspepsia—Methotrexate—systemic scleroderma	7.64e-05	0.000264	CcSEcCtD
Raltegravir—Decreased appetite—Methotrexate—systemic scleroderma	7.54e-05	0.00026	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.49e-05	0.000259	CcSEcCtD
Raltegravir—Fatigue—Methotrexate—systemic scleroderma	7.48e-05	0.000258	CcSEcCtD
Raltegravir—Asthenia—Prednisone—systemic scleroderma	7.45e-05	0.000257	CcSEcCtD
Raltegravir—Pain—Methotrexate—systemic scleroderma	7.42e-05	0.000256	CcSEcCtD
Raltegravir—Pruritus—Prednisone—systemic scleroderma	7.35e-05	0.000254	CcSEcCtD
Raltegravir—Feeling abnormal—Methotrexate—systemic scleroderma	7.15e-05	0.000247	CcSEcCtD
Raltegravir—Diarrhoea—Prednisone—systemic scleroderma	7.1e-05	0.000245	CcSEcCtD
Raltegravir—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.1e-05	0.000245	CcSEcCtD
Raltegravir—Urticaria—Methotrexate—systemic scleroderma	6.89e-05	0.000238	CcSEcCtD
Raltegravir—Dizziness—Prednisone—systemic scleroderma	6.87e-05	0.000237	CcSEcCtD
Raltegravir—Abdominal pain—Methotrexate—systemic scleroderma	6.86e-05	0.000237	CcSEcCtD
Raltegravir—Body temperature increased—Methotrexate—systemic scleroderma	6.86e-05	0.000237	CcSEcCtD
Raltegravir—Vomiting—Prednisone—systemic scleroderma	6.6e-05	0.000228	CcSEcCtD
Raltegravir—Rash—Prednisone—systemic scleroderma	6.55e-05	0.000226	CcSEcCtD
Raltegravir—Dermatitis—Prednisone—systemic scleroderma	6.54e-05	0.000226	CcSEcCtD
Raltegravir—Headache—Prednisone—systemic scleroderma	6.51e-05	0.000225	CcSEcCtD
Raltegravir—Hypersensitivity—Methotrexate—systemic scleroderma	6.39e-05	0.000221	CcSEcCtD
Raltegravir—Asthenia—Methotrexate—systemic scleroderma	6.23e-05	0.000215	CcSEcCtD
Raltegravir—Nausea—Prednisone—systemic scleroderma	6.17e-05	0.000213	CcSEcCtD
Raltegravir—Pruritus—Methotrexate—systemic scleroderma	6.14e-05	0.000212	CcSEcCtD
Raltegravir—Diarrhoea—Methotrexate—systemic scleroderma	5.94e-05	0.000205	CcSEcCtD
Raltegravir—Dizziness—Methotrexate—systemic scleroderma	5.74e-05	0.000198	CcSEcCtD
Raltegravir—Vomiting—Methotrexate—systemic scleroderma	5.52e-05	0.00019	CcSEcCtD
Raltegravir—Rash—Methotrexate—systemic scleroderma	5.47e-05	0.000189	CcSEcCtD
Raltegravir—Dermatitis—Methotrexate—systemic scleroderma	5.47e-05	0.000189	CcSEcCtD
Raltegravir—Headache—Methotrexate—systemic scleroderma	5.44e-05	0.000188	CcSEcCtD
Raltegravir—Nausea—Methotrexate—systemic scleroderma	5.15e-05	0.000178	CcSEcCtD
